Next Article in Journal
Radiation-Induced Recurrent Vesicovaginal Fistula—Treatment with Adjuvant Platelet-Rich Plasma Injection and Martius Flap Placement—Case Report and Review of Literature
Next Article in Special Issue
Prevalence and Factors Associated with Musculoskeletal Disorders among Secondary Schoolteachers in Hail, Saudi Arabia: A Cross-Sectional Survey
Previous Article in Journal
Coping and Post-Traumatic Stress in Children and Adolescents after an Acute Onset Disaster: A Systematic Review
Previous Article in Special Issue
Effect of Myofascial Therapy on Pain and Functionality of the Upper Extremities in Breast Cancer Survivors: A Systematic Review and Meta-Analysis
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Risk of Mortality and Readmission among Patients with Pelvic Fracture and Urinary Tract Infection: A Population-Based Cohort Study

1
Institute of Medicine, Chung Shan Medical University, Taichung 402, Taiwan
2
Department of Surgery, Changhua Christian Hospital, Changhua 500, Taiwan
3
School of Medicine, Chung Shan Medical University, Taichung 402, Taiwan
4
Department of Emergency Medicine, Chung Shan Medical University Hospital, Taichung 402, Taiwan
5
Department of Psychiatry, Chung Shan Medical University Hospital, Taichung 402, Taiwan
6
School of Medicine, Chang Gung University, Taoyuan 333, Taiwan
7
Department of Medical Research, Chung Shan Medical University Hospital, Taichung 402, Taiwan
8
Institute of Oral Sciences, Chung Shan Medical University, Taichung 402, Taiwan
9
Graduate School of Dentistry, School of Dentistry, Chung Shan Medical University, Taichung 402, Taiwan
10
Department of Dentistry, Chung Shan Medical University Hospital, Taichung 402, Taiwan
11
Department of Microbiology and Immunology, Chung Shan Medical University, Taichung 402, Taiwan
*
Authors to whom correspondence should be addressed.
Int. J. Environ. Res. Public Health 2021, 18(9), 4868; https://doi.org/10.3390/ijerph18094868
Submission received: 16 April 2021 / Revised: 28 April 2021 / Accepted: 30 April 2021 / Published: 3 May 2021
(This article belongs to the Special Issue Musculoskeletal Disorders, Physical Rehabilitation and Health)

Abstract

:
Patients with pelvic fractures could encounter various complications during or after treatments. This cohort study investigated the risk of mortality and readmissions in patients with pelvic fractures, with or without urinary tract infections (UTIs), within 30 days following the pelvic fractures. This retrospective cohort study examined claim records from the Longitudinal Health Insurance Database 2000 (LHID2000). We selected patients hospitalized with pelvic fractures between 1997 and 2013 for study. Patients who had index data before 2000 or after 2010 (n = 963), who died before the index date (n = 64), who were aged <18 years (n = 94), or who had a pelvic injury (n = 31) were excluded. In total, the study cohort comprised 1623 adult patients; 115 had UTIs, and 1508 patients without UTIs were used as a comparison cohort. Multivariate analysis with a multiple Cox regression model and Kaplan–Meier survival analysis were performed to analyze the data. Our results showed that the 1-year mortality rate (adjusted hazard ratio [HR]: 2.32; 95% CI: 1.25–4.29) and readmission rate (adjusted HR: 1.72; 95% CI: 1.26–3.34) of the UTI group were significantly higher than those of the non-UTI group. Moreover, the Kaplan–Meier curve for the 1-year follow-up indicated that the UTI group had a higher cumulative risk of both mortality and hospital readmission compared with the non-UTI group. In conclusion, among patients with pelvic fracture, patients with UTI were associated with increased risks of mortality and readmission. Physicians must pay more attention to such patients to prevent UTIs among patients with pelvic fractures during hospitalization and conduct a follow-up after discharge within at least 1 year.

1. Introduction

Pelvic fractures can occur due to low-to-high energy compression and trauma. The mortality rate for severe cases of pelvic fractures could be is >40% [1]. However, patient mortality is not always caused directly by the fractures themselves; major organ injuries, hemodynamic instability, and infection are possible causes [1,2]. Unstable pelvic ring injuries and internal bleeding, especially those caused by arterial mass hemorrhage, considerably increase mortality [3,4]. Therefore, controlling serious hemorrhages, stabilizing fractures, and avoiding urinary tract injuries are interventions critical to decreasing associated mortality rates [5,6].
Certain complications can occur in patients with pelvic fractures, including pseudoaneurysms, renal failure, soft-tissue necrosis/infections, and anaphylactic reactions, especially when the approach of pelvic angiography with transcatheter arterial embolization is used to control pelvic arterial hemorrhage [7]. Pelvic ring disruption could also cause injuries to neurovascular structures and other organ systems. Additionally, a study demonstrated that approximately 25% of patients with pelvic ring disruption had lower urinary tract injuries. Recently, a systematic review revealed that approximately 29% of patients with pelvic fracture presented with genitourinary (bladder, urethra, and ureter) injuries [8]. These patients had potential urine contamination and urinary tract infections (UTIs). Furthermore, infectious complications, including pneumonia, UTI, surgical site infection, sepsis, and septic shock, have been noted in patients following pelvic fracture surgery [9]. However, there was little research about the mortality and readmission risk of the pelvic fracture patients when acquiring those complications.
A UTI was one of the common and early urinary complications with a pelvic fracture [10]. Surveillance and adequate treatment of UTIs were essential for patients with pelvic fractures for the following reasons: (1) for critical care of pelvic fracture patients in the intensive care unit, UTIs, and further, urosepsis and septic shock, all put patients at a higher risk of mortality [11]. Meanwhile, these patients may need prolonged urinary or suprapubic catheterization for the urinary tract injury from the pelvic. Moreover, repeated UTIs could increase the risk of genitourinary tract cancer [12]. (2) Stability of the biomechanical environment played a vital role in wound and fracture healing. Infection could affect the healing process by interrupting osteogenesis of osteoblast [13]. (3) A previous study showed that UTI increased the risk of longer hospitalization, more than 5 days in hip fracture [14]. However, there were no such data on the risk of adverse outcome of UTIs after pelvic fracture surgery in regards to the importance and necessity of these clinical circumstances.
The Poisson regression had residuals that were assumed to follow the Poisson distribution, when estimating the probability of a count of study events within a given time [15]. Moreover, the Cox regression and Kaplan–Meier analysis provided the hazard ratio and cumulative probability over follow-up time. Hung et al. estimated the risk of oral cancer in a high-risk individual and estimated the predictive model; they used Poisson regression analysis to calculate the incidence density ratio of oral cancer between groups, and a Cox proportional-hazards model was used to explore the risk factors of oral cancer incidence [16].
In the present study, we evaluated the risks of mortality and readmission due to a UTI within 30 days among patients with pelvic fractures. We hypothesized that patients with pelvic fractures accompanied by UTIs would have an increased risk of mortality and readmission.

2. Materials and Methods

2.1. Data Sources

We used data from the Longitudinal Health Insurance Database (LHID) 2000, a subset of the National Health Insurance Research Database, to evaluate the risk of mortality and the readmission rates among patients with or without UTIs following pelvic fracture surgery. The LHID2000 comprises the data of 1 million beneficiaries who insured by the National Health Insurance program in 2000. The research period of the present study was from 1 January 1997 to 31 December 2013 (17 years). This retrospective population-based cohort study was approved by the National Health Insurance Administration and the Institutional Review Board of Chung Shan Medical University (registration number: CSMUH CS16183).

2.2. Study Population

First, we included 2775 patients were hospitalized for pelvic fracture (as defined by the International Classification of Diseases, Ninth Revision, Clinical Modification [ICD-9-CM] code 808) between 1 January 1997 and 31 December 2013. The index date was 30 days after admission with a primary diagnosis of pelvic fracture. Second, we excluded patients who (a) had index dates before January 2001 (for left-censored or left-truncated data) or after December 2010 (limited due to the research timeframe); (b) died before the index date; (c) were aged <18 years, as the musculoskeletal conditions were not fully developed, which was a confounding factor; or (d) had injuries to pelvic organs, because this situation was a bias of mortality with readmission complications, and was not caused by pelvic fractures, but by pelvic organs injuries. Consequently, 1623 patients, including 115 patients with UTIs and 1508 patients without UTIs, were selected for analyses. Figure 1 illustrates the present study’s framework.

2.3. Characteristics, Comorbidities, and Study Outcomes

Baseline demographic characteristics, such as age and sex, were recorded. Comorbidities, including hypertension, diabetes mellitus, hyperlipidemia, coronary artery disease, previous incidence of a cerebrovascular accident, chronic kidney disease (CKD), COPD, chronic liver diseases, heart failure, depression, osteoporosis, asthma, and osteoarthritis within 1 year prior to the index date, were documented as potential confounding factors. The study outcomes were death and readmission. All included individuals received follow-ups from the index date to either the study event, the date of death, or the study’s conclusion (31 December 2013).

2.4. Statistical Analysis

Categorical data are presented as numbers and percentages; they were compared using a chi-squared test. The incidence rate with corresponding CIs and crude hazard ratios (HRs) were calculated using Poisson regression. After the proportional hazards assumption was tested, a Cox proportional hazards model analysis was performed to estimate the readmission rates, HRs for mortality, and 95% CIs. Statistical analysis was performed using SAS software version 9.4 (SAS Institute, Cary, NC, USA), and a p-value of <0.05 was considered statistically significant. The cumulative probabilities of mortality and readmission were assessed using a Kaplan–Meier analysis, in which statistical significance was determined by the results of a log-rank test.

3. Results

3.1. Characteristics of Study Patients

We identified 1623 patients who had been hospitalized for pelvic fracture from 1997 to 2013. Of these, including 115 with UTIs and 1508 without UTIs, were for analysis. Table 1 shows the baseline characteristics of the study participants. The proportion of female patients (73.91%) and patients over 65 years of age (45.22%) with UTIs was significantly higher than patients without UTIs. Compared with the non-UTI group, the UTI group had an older average age, and higher prevalence of comorbidities, such as hypertension, diabetes mellitus, hyperlipidemia, history of cerebrovascular accidents, chronic kidney disease (CKD), and heart failure, at baseline.

3.2. Risk of UTI after Exposure to Pelvic Fracture

We analyzed the incidence rates and HRs of mortality and hospital readmission among patients with pelvic fractures who did or did not have UTIs. The incidence rate of mortality among the UTI group increased at 3 months (adjusted HR: 2.50; 95% CI: 1.05–5.95), 6 months (adjusted HR: 2.31; 95% CI: 1.11–4.78), 9 months (adjusted HR: 2.71; 95% CI: 1.44–5.11), and 1 year (adjusted HR: 2.32; 95% CI: 1.25–4.29) after the index date. Additionally, the incidence rate of hospital readmission among the UTI group increased at 1 month (adjusted HR: 2.95; 95% CI: 1.71–5.10), 2 months (adjusted HR: 2.68; 95% CI: 1.73–4.15), 3 months (adjusted HR: 2.53; 95% CI: 1.71–3.73), 6 months (adjusted HR: 1.98; 95% CI: 1.40–2.80), 9 months (adjusted HR: 1.83; 95% CI: 1.33–2.51), and 1 year (adjusted HR: 1.72; 95% CI: 1.26–3.34) after the index date (Table 2).
We estimated the cumulative incidence of mortality and hospital readmission among patients in the UTI and non-UTI groups. The Kaplan–Meier curve for 1-year follow-up (Figure 2) indicated that those in the UTI group had an increased cumulative risk of both mortality (panel a, log-rank test p < 0.001) and hospital readmission (panel b, log-rank test p < 0.001) compared with the non-UTI group.
We used multiple Cox regression to estimate the hazard ratio (HR) for mortality and hospital readmission in the UTI group. The Cox regression was also used to explore the potential risk factors in the past study [17]. The results showed that the risk of both mortality (adjusted HR: 2.32; 95% CI: 1.25–4.29) and hospital readmission (adjusted HR: 1.72; 95% CI: 1.26–2.34) increased in the UTI group. Mortality and hospital readmission risks also increased in patients aged >65 years (Table 3). Patients with comorbidities, such as diabetes, previous cerebrovascular accidents, chronic kidney disease (CKD), chronic obstructive pulmonary disease (COPD) chronic liver diseases, osteoporosis, asthma, and osteoarthritis, had a higher risk of hospital readmission. Moreover, patients with CKD and heart failure had a higher mortality risk. Furthermore, patients who had received surgery for a UTI had a higher risk of hospital readmission (Table 3).

4. Discussion

We compared patients with pelvic fractures, with or without UTIs, to estimate the risk of mortality and hospital readmission. Our results demonstrated that risks of mortality and readmission increased in patients with pelvic fracture after 1 year if they had a UTI within 30 days of admission for pelvic fracture. The pelvic ring mainly consists of the sacrum, coccyx, pubis, ischium, and ilium. The pelvic cavity contains blood vessels, nerves, urogenital organs, and the rectum, which are important vitals in human. Hence, pelvic fracture is associated with a higher risk of injury to these internal organs and tissues [18]. In the present study, many injuries and complications occurred in patients with pelvic fractures after surgery. For example, unstable fractures were associated with complications such as retroperitoneal hematoma, injuries to the urethra or bladder, rectal injuries, and sciatic nerve damage [19]. This phenomenon might be related to postoperative medical care after discharge. By using national trauma data, Bjurlin et al. observed that 4.6% of patients with pelvic fractures had complications of genitourinary injuries [20]. Additionally, other complications, such as chest or wound infections and pain, might occur [21]. Due to the pain related to the injuries to their urinary systems, patients might exhibit difficulty passing urine. In this case, a urine catheter would always be required for urine drainage. Therefore, UTI risk may increase due to repeated catheterization [22].
In our study, we compared the incidence rates of both readmission and mortality among UTI and non-UTI patients after pelvic fracture. We found that the incidence density and adjusted hazard ratio (aHR) of readmission in the UTI group were higher than those in the non-UTI group, in each observed interval, from the index date to 1 year after the index date. Moreover, the incidence density and adjusted hazard ratio (aHR) of mortality in the UTI group were significantly higher than in the non-UTI group between the third month and 1 year after the index date. These results indicated that patients with pelvic fracture who experienced UTI complications postoperatively had a higher risk of both readmission and mortality up to 1 year after surgery. Malik et al. investigated the cause of readmission within 30 days due to adverse events among patients with pelvic/acetabular fractures. Malik et al. determined that many factors affected patient readmission, mortality, and other adverse events. For example, poor health status and concurrent comorbidities increased patients’ risks of adverse events after surgery. They also classified these adverse events into major (e.g., mortality) and minor ones (e.g., UTI) [9]. Dwyer and Moed observed that a small proportion of patients with a pelvic ring or acetabular fracture developed venous thromboembolism (VTE) within 90 days after hospital discharge [23]. The results of these studies allowed us to infer that different complications and adverse events could increase readmission and mortality rates in patients with pelvic fractures after surgery.
Poole and Ward observed that the overall mortality rate among approximately 500 patients who had an average age of 30 years, and average hospital stay of 16.5 days, was 8% [24]. Poole and Ward also noted that only 14.3% of deaths were directly associated with pelvic fracture. Most deaths were due to non-pelvic hemorrhage, multiple organ failure, and severe head injury [24]. In another retrospective study, in which 343 patients with pelvic fractures were enrolled, the overall mortality rate was 10.5% [25]. Chong et al. determined that one-third the related mortality rate was directly related to pelvic fracture, and another third of them was associated with complications [25]. In a national study of 31,380 patients with pelvic fractures, compared with patients without genitourinary injuries, those with such injuries were observed to have longer hospital stays, higher utilization of intensive care units, and an increased mortality rate (13.99% among patients with genitourinary injuries vs. 8.08% among patients without genitourinary injuries) [20].
Most studies have focused on the impact of readmission on hip fracture. Regardless of the different anatomical locations of both types of fractures, the available information on hip fracture in the literature might provide a key reference for those treating patients with pelvic fracture. Owing to the closely anatomical positions of hip and pelvic fractures, it was worth it to use relevant articles about hip fracture to explain our study. In fact, our study indicated that pelvic fracture patients complicated with UTI would have higher risk on mortality and readmission. The main cause of readmission among patients with hip fracture might be related to the development of certain medical complications after hospital discharge. Additionally, many predictors forecasted readmission among patients. A study in which patients with hip fractures were followed up for 1 year indicated that the associated readmission rate could be up to 21%; the main causes included bronchopneumonia, falls, urosepsis, cardiac exacerbations, and stroke after discharge [26]. Other predictors for readmission included pulmonary disease, deep vein thrombosis, heart failure, renal failure, sex, prolonged surgery time (i.e., >24 h), and preexisting diseases [27,28,29,30]. Moreover, fracture severity and advanced patient age were associated with higher mortality rates among patients with pelvic fractures [25]. Bjurlin et al. indicated that genitourinary injuries were not an independent factor behind mortality, but independent predictors were age of ≥65 years, initial systolic blood pressure measurements in the emergency department, Injury Severity Score, Glasgow Coma Scale, and female sex [20].
Some predictors of the mortality rates of patients with hip fracture after discharge have also been identified. Heyes’ group also studied the 1-year mortality rate among 465 patients with hip fracture. They determined the overall 1-year mortality rate to be 15.1%. Patients with a surgery time of ≥36 h had an increased risk of mortality within 1 year of surgery. Mortality risks were also associated with increased comorbidity, surgery type, independence following discharge, alcohol intake, history of smoking, readmission, and several biochemical markers [31]. More importantly, 1-year mortality among readmitted patients or patients with prolonged hospital stays was quite high [30]. Hence, our results indicated that UTIs might act as a mortality predictor among patients with pelvic fracture.
Some studies have reported that patients with pelvic fractures had high incidences of chronic pain and inhibited movement [32,33]. For this reason, we proposed that the patients hold their urine for a longer period of time. However, several reports have indicated that the prolonged holding of urine could allow for bacteria growth and increase the risk of a UTI [34,35,36]. Therefore, this factor may have increased the likelihood of such patients in developing a UTI. Moreover, our study results show that UTIs are common complications of pelvic fractures, and the mortality and rehospitalization rates of patients with UTIs are significantly higher than non-UTI patients. Therefore, more attention and aggressive treatments for these patients is our recommendation.
To enroll only patients with pelvic fractures, we excluded those who were diagnosed as having only an injury to the pelvis rather than pelvic fracture. However, some limitations in this study persisted. First, the database could not provide information regarding the severity and types of pelvic fractures in patients, such as ratings according to the Injury Severity Score and Glasgow Coma Scale. These scores might affect mortality and hospital readmission risks. Second, we did not know how much time passed between the pelvic fracture event and the time of surgery. However, delaying surgery might affect the prognosis of the fracture and increase the risk of readmission and mortality.

5. Conclusions

In conclusion, UTI could act as a risk factor and a predictor for patients with pelvic fractures. UTI complications experienced within 30 days could increase the risk of mortality and hospital readmission. To reduce the mortality of patients and to diminish medical burdens, physicians must pay more attention to postoperative care and monitor the conditions of these patients after discharge to prevent UTI complications.

Author Contributions

Conceptualization, Y.-C.C., C.-H.C. (Cheng-Hsun Chuang), and C.-B.Y.; formal analysis, M.-H.H., H.-W.Y., C.-W.L., Y.-T.Y., J.-Y.H., and P.-L.L.; writing—original draft preparation, Y.-C.C., S.-F.Y., C.-H.C. (Cheng-Hsun Chuang), and C.-B.Y.; writing—review and editing, Y.-C.C., S.-F.Y., C.-H.C. (Chi-Ho Chan), and C.-B.Y. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

The study was conducted according to the guidelines of the Declaration of Helsinki, and approved by the Ethical Review Board of the Chung Shan Medical University Hospital (CS16183) approved our study.

Informed Consent Statement

Patient consent was waived by both the National Health Insurance Administration and the Institutional Review Board of Chung Shan Medical University Hospital due to the database-processing nature of the current study.

Data Availability Statement

Restrictions apply to the availability of these data. Data were obtained from the National Health Insurance database, and are available from the authors, with the permission of the National Health Insurance Administration of Taiwan.

Acknowledgments

This study was partially based on data from the NHIRD provided by the NHI Administration, Ministry of Health, and Welfare, and managed by the National Health Research Institutes. The interpretation and conclusions contained herein do not represent those of the NHI Administration, Ministry of Health, and Welfare, or the National Health Research Institutes.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Shim, H.; Jang, J.Y.; Kim, J.W.; Ryu, H.; Jung, P.Y.; Kim, S.; Kwon, H.Y.; Kim, K.M.; Chung, H.; Bae, K.S. Effectiveness and postoperative wound infection of preperitoneal pelvic packing in patients with hemodynamic instability caused by pelvic fracture. PLoS ONE 2018, 13, e0206991. [Google Scholar] [CrossRef] [PubMed]
  2. Jerrard, D.A. Pelvic fractures. Emerg. Med. Clin. N. Am. 1993, 11, 147–163. [Google Scholar] [CrossRef]
  3. Kobziff, L. Traumatic pelvic fractures. Orthop. Nurs. 2006, 25, 235–241. [Google Scholar] [CrossRef]
  4. Rodrigues, I. To log-roll or not to log-roll—that is the question! A review of the use of the log-roll for patients with pelvic fractures. Int. J. Orthop. Trauma Nurs. 2017, 27, 36–40. [Google Scholar] [CrossRef] [PubMed]
  5. Flint, L.; Cryer, H.G. Pelvic fracture: The last 50 years. J. Trauma 2010, 69, 483–488. [Google Scholar] [CrossRef] [Green Version]
  6. Wong, J.M.; Bucknill, A. Fractures of the pelvic ring. Injury 2017, 48, 795–802. [Google Scholar] [CrossRef]
  7. Wiley, M.; Black, S.; Martin, C.; Barnwell, J.; Starr, A.; Sathy, A. Complications after pelvic arteriography in patients with pelvic ring disruptions. J. Am. Acad. Orthop. Surg. 2018, 26, 765–772. [Google Scholar] [CrossRef]
  8. Lee, M.J.; Wright, A.; Cline, M.; Mazza, M.B.; Alves, T.; Chong, S. Pelvic fractures and associated genitourinary and vascular injuries: A multisystem review of pelvic trauma. AJR Am. J. Roentgenol. 2019, 213, 1297–1306. [Google Scholar] [CrossRef] [PubMed]
  9. Malik, A.T.; Quatman, C.E.; Phieffer, L.S.; Jain, N.; Khan, S.N.; Ly, T.V. 30-day adverse events, length of stay and re-admissions following surgical management of pelvic/acetabular fractures. J. Clin. Orthop. Trauma 2019, 10, 890–895. [Google Scholar] [CrossRef]
  10. Eid, A.M. Early urinary complications of fractures of the pelvis. Arch. Orthop. Trauma Surg. 1982, 100, 99–106. [Google Scholar] [CrossRef]
  11. Laupland, K.B.; Bagshaw, S.M.; Gregson, D.B.; Kirkpatrick, A.W.; Ross, T.; Church, D.L. Intensive care unit-acquired urinary tract infections in a regional critical care system. Crit. Care 2005, 9, R60–R65. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  12. Huang, C.H.; Chou, Y.H.; Yeh, H.W.; Huang, J.Y.; Yang, S.F.; Yeh, C.B. Risk of cancer after lower urinary tract infection: A population-based cohort study. Int. J. Environ. Res. Public Health 2019, 16, 390. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  13. Foster, A.L.; Moriarty, T.F.; Zalavras, C.; Morgenstern, M.; Jaiprakash, A.; Crawford, R.; Burch, M.A.; Boot, W.; Tetsworth, K.; Miclau, T.; et al. The influence of biomechanical stability on bone healing and fracture-related infection: The legacy of stephan perren. Injury 2021, 52, 43–52. [Google Scholar] [CrossRef]
  14. Crouser, N.; Malik, A.T.; Phieffer, L.S.; Ly, T.V.; Khan, S.N.; Quatman, C.E. Urinary tract infection (uti) at time of geriatric hip fracture surgery increases the risk of experiencing adverse 30-day outcomes. J. Clin. Orthop. Trauma 2019, 10, 774–778. [Google Scholar] [CrossRef] [PubMed]
  15. Du, J.; Park, Y.T.; Theera-Ampornpunt, N.; McCullough, J.S.; Speedie, S.M. The use of count data models in biomedical informatics evaluation research. J. Am. Med. Inform. Assoc. 2012, 19, 39–44. [Google Scholar] [CrossRef] [Green Version]
  16. Hung, L.C.; Kung, P.T.; Lung, C.H.; Tsai, M.H.; Liu, S.A.; Chiu, L.T.; Huang, K.H.; Tsai, W.C. Assessment of the risk of oral cancer incidence in a high-risk population and establishment of a predictive model for oral cancer incidence using a population-based cohort in taiwan. Int. J. Environ. Res. Public Health 2020, 17, 665. [Google Scholar] [CrossRef] [Green Version]
  17. Ahmad, R.; Bath, P.A. Identification of risk factors for 15-year mortality among community-dwelling older people using cox regression and a genetic algorithm. J. Gerontol. A Biol. Sci. Med. Sci. 2005, 60, 1052–1058. [Google Scholar] [CrossRef] [Green Version]
  18. Starr, A.J.; Griffin, D.R.; Reinert, C.M.; Frawley, W.H.; Walker, J.; Whitlock, S.N.; Borer, D.S.; Rao, A.V.; Jones, A.L. Pelvic ring disruptions: Prediction of associated injuries, transfusion requirement, pelvic arteriography, complications, and mortality. J. Orthop. Trauma 2002, 16, 553–561. [Google Scholar] [CrossRef]
  19. Watnik, N.F.; Coburn, M.; Goldberger, M. Urologic injuries in pelvic ring disruptions. Clin. Orthop. Relat. Res. 1996, 329, 37–45. [Google Scholar] [CrossRef]
  20. Bjurlin, M.A.; Fantus, R.J.; Mellett, M.M.; Goble, S.M. Genitourinary injuries in pelvic fracture morbidity and mortality using the national trauma data bank. J. Trauma 2009, 67, 1033–1039. [Google Scholar] [CrossRef]
  21. Poole, G.V.; Ward, E.F.; Griswold, J.A.; Muakkassa, F.F.; Hsu, H.S. Complications of pelvic fractures from blunt trauma. Am. Surg. 1992, 58, 225–231. [Google Scholar]
  22. Johnsen, N.V.; Vanni, A.J.; Voelzke, B.B. Risk of infectious complications in pelvic fracture urethral injury patients managed with internal fixation and suprapubic catheter placement. J. Trauma Acute Care Surg. 2018, 85, 536–540. [Google Scholar] [CrossRef]
  23. Dwyer, E.P.; Moed, B.R. Venous thromboembolism after hospital discharge in pelvic and acetabular fracture patients treated operatively. J. Orthop. Surg. 2019, 27, 2309499019832815. [Google Scholar] [CrossRef] [PubMed]
  24. Poole, G.V.; Ward, E.F. Causes of mortality in patients with pelvic fractures. Orthopedics 1994, 17, 691–696. [Google Scholar] [CrossRef]
  25. Chong, K.H.; DeCoster, T.; Osler, T.; Robinson, B. Pelvic fractures and mortality. Iowa Orthop. J. 1997, 17, 110–114. [Google Scholar] [PubMed]
  26. Heyes, G.J.; Tucker, A.; Marley, D.; Foster, A. Predictors for readmission up to 1 year following hip fracture. Arch. Trauma Res. 2015, 4, e27123. [Google Scholar]
  27. Kates, S.L.; Behrend, C.; Mendelson, D.A.; Cram, P.; Friedman, S.M. Hospital readmission after hip fracture. Arch. Orthop. Trauma Surg. 2015, 135, 329–337. [Google Scholar] [CrossRef] [PubMed]
  28. Lizaur-Utrilla, A.; Serna-Berna, R.; Lopez-Prats, F.A.; Gil-Guillen, V. Early rehospitalization after hip fracture in elderly patients: Risk factors and prognosis. Arch. Orthop. Trauma Surg. 2015, 135, 1663–1667. [Google Scholar] [CrossRef]
  29. Pollock, F.H.; Bethea, A.; Samanta, D.; Modak, A.; Maurer, J.P.; Chumbe, J.T. Readmission within 30 days of discharge after hip fracture care. Orthopedics 2015, 38, e7–e13. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  30. Lee, T.C.; Ho, P.S.; Lin, H.T.; Ho, M.L.; Huang, H.T.; Chang, J.K. One-year readmission risk and mortality after hip fracture surgery: A national population-based study in taiwan. Aging Dis. 2017, 8, 402–409. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  31. Heyes, G.J.; Tucker, A.; Marley, D.; Foster, A. Predictors for 1-year mortality following hip fracture: A retrospective review of 465 consecutive patients. Eur. J. Trauma Emerg. Surg. 2017, 43, 113–119. [Google Scholar] [CrossRef] [PubMed]
  32. Meyhoff, C.S.; Thomsen, C.H.; Rasmussen, L.S.; Nielsen, P.R. High incidence of chronic pain following surgery for pelvic fracture. Clin. J. Pain 2006, 22, 167–172. [Google Scholar] [CrossRef] [PubMed]
  33. Gerbershagen, H.J.; Dagtekin, O.; Isenberg, J.; Martens, N.; Ozgür, E.; Krep, H.; Sabatowski, R.; Petzke, F. Chronic pain and disability after pelvic and acetabular fractures--assessment with the mainz pain staging system. J. Trauma 2010, 69, 128–136. [Google Scholar] [CrossRef] [PubMed]
  34. Minardi, D.; d’Anzeo, G.; Cantoro, D.; Conti, A.; Muzzonigro, G. Urinary tract infections in women: Etiology and treatment options. Int. J. Gen. Med. 2011, 4, 333–343. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  35. Aslam, S.; Albo, M.; Brubaker, L. Recurrent urinary tract infections in adult women. JAMA 2020, 323, 658–659. [Google Scholar] [CrossRef] [PubMed]
  36. Shih, W.Y.; Chang, C.C.; Tsou, M.T.; Chan, H.L.; Chen, Y.J.; Hwang, L.C. Incidence and risk factors for urinary tract infection in an elder home care population in taiwan: A retrospective cohort study. Int. J. Environ. Res. Public Health 2019, 16, 566. [Google Scholar] [CrossRef] [PubMed] [Green Version]
Figure 1. Flowchart for patient selection.
Figure 1. Flowchart for patient selection.
Ijerph 18 04868 g001
Figure 2. Kaplan–Meier curves of the cumulative proportions of mortality (a) and re-admission (b) in UTI and non-UTI.
Figure 2. Kaplan–Meier curves of the cumulative proportions of mortality (a) and re-admission (b) in UTI and non-UTI.
Ijerph 18 04868 g002
Table 1. Baseline characteristics among study groups.
Table 1. Baseline characteristics among study groups.
VariablesNon-UTI
n = 1508
UTI
n = 115
p-Value
Sex <0.0001
Female823(54.58%)85(73.91%)
Male685(45.42%)30(26.09%)
Age <0.0001
18–40551(36.54%)31(26.96%)
41–65566(37.53%)32(27.83%)
>65391(25.93%)52(45.22%)
Comorbidities
Hypertension358(23.74%)52(45.22%)<0.0001
Diabetes mellitus216(14.32%)31(26.96%)0.0003
Hyperlipidemia145(9.62%)23(20%)0.0004
Coronary artery disease165(10.94%)17(14.78%)0.2083
Cerebrovascular accident131(8.69%)23(20%)<0.0001
CKD114(7.56%)15(13.04%)0.0361
COPD169(11.21%)16(13.91%)0.3787
Chronic liver diseases183(12.14%)18(15.65%)0.2698
Heart failure72(4.77%)14(12.17%)0.0006
Depression223(14.79%)19(16.52%)0.6148
Osteoporosis233(15.45%)25(21.74%)0.0755
Asthma75(4.97%)9(7.83%)0.1832
Osteoarthritis378(25.07%)37(32.17%)0.0922
Surgery for pelvic fracture177(11.74%)11(9.57%)0.4829
Table 2. Incidence rate for the mortality risk and re-admission.
Table 2. Incidence rate for the mortality risk and re-admission.
VariableIncidence Density * (95% CI)cRR * (95% CI)p-ValueaHR * (95% CI)p-Value
Non-UTIUTI
Mortality
from index date to
1 m0.60(0.31–1.17)2.67(0.86–8.30)4.37(1.18–16.1)0.02682.48(0.63–9.66)0.1897
2 m0.54(0.33–0.88)2.25(0.93–5.41)4.12(1.51–11.2)0.00562.43(0.84–7.03)0.1000
3 m0.49(0.32–0.75)2.44(1.22–4.89)4.87(2.16–10.9)0.00012.50(1.05–5.95)0.0369
6 m0.38(0.27–0.53)1.72(0.95–3.12)4.39(2.22–8.67)<0.00012.31(1.11–4.78)0.0241
9 m0.31(0.22–0.42)1.59(0.96–2.64)5.02(2.78–9.07)<0.00012.71(1.44–5.11)0.0019
1 year0.28(0.21–0.37)1.19(0.71–1.98)4.14(2.32–7.38)<0.00012.32(1.25–4.29)0.0070
Readmission
from index date to
1 m4.93(3.90–6.22)18.1(11.4–28.8)3.47(2.07–5.83)<0.00012.95(1.71–5.10)0.0001
2 m4.52(3.80–5.38)14.5(9.95–21.1)3.04(2.00–4.60)<0.00012.68(1.73–4.15)<0.0001
3 m4.16(3.59–4.83)12.3(8.78–17.3)2.80(1.93–4.07)<0.00012.53(1.71–3.73)<0.0001
6 m3.44(3.05–3.87)8.17(6.00–11.1)2.25(1.61–3.14)<0.00011.98(1.40–2.80)<0.0001
9 m2.99(2.68–3.32)6.61(4.95–8.83)2.11(1.55–2.87)<0.00011.83(1.33–2.51)0.0002
1 year2.61(2.37–2.89)5.47(4.13–7.24)1.98(1.47–2.67)<0.00011.72(1.26–2.34)0.0005
* Incidence rate, per 100 person months; cRR *, crude relative risk; aHR *, adjusted hazard ratio: adjusted for all variables.
Table 3. Multiple Cox regression to estimate the hazard ratio for the mortality risk and re-admission.
Table 3. Multiple Cox regression to estimate the hazard ratio for the mortality risk and re-admission.
VariableMortalityRe-Admission
aHR (95% CI)p-ValueaHR (95% CI) *p-Value
UTI
NoReference Reference
Yes2.32(1.25–4.29)0.00701.72(1.26–2.34)0.0005
Sex
FemaleReference Reference
Male1.19(0.68–2.09)0.52481.23(1.01–1.51)0.0382
Age
18–40Reference Reference
41–651.34(0.38–4.70)0.64341.01(0.77–1.32)0.9209
>656.55(2.03–21.0)0.00161.57(1.14–2.14)0.0047
Comorbidities (ref: non)
Hypertension1.16(0.63–2.15)0.62290.99(0.76–1.28)0.9528
Diabetes mellitus1.05(0.58–1.91)0.8511.51(1.17–1.94)0.0014
Hyperlipidemia0.54(0.25–1.15)0.11420.79(0.58–1.06)0.1254
Coronary artery disease0.55(0.29–1.02)0.05810.88(0.66–1.18)0.4048
Cerebrovascular accident1.54(0.84–2.82)0.15541.35(1.02–1.78)0.0328
CKD2.80(1.60–4.90)0.00031.59(1.19–2.12)0.0016
COPD1.84(1.01–3.37)0.04541.47(1.12–1.93)0.0045
Chronic liver diseases1.42(0.79–2.58)0.23841.46(1.13–1.87)0.0028
Heart failure2.79(1.54–5.06)0.00071.35(0.96–1.91)0.0777
Depression1.09(0.58–2.05)0.77171.20(0.94–1.53)0.1335
Osteoporosis0.94(0.53–1.67)0.84291.49(1.17–1.90)0.0010
Asthma1.51(0.76–3.00)0.23491.46(1.01–2.09)0.0411
Osteoarthritis1.39(0.81–2.39)0.23061.28(1.03–1.58)0.0226
Surgery
NoReference Reference
Yes0.58(0.13–2.50)0.46911.82(1.38–2.40)<0.0001
* aHR, Adjusted Hazard Ratio: Adjusted for all variables.
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Chen, Y.-C.; Chuang, C.-H.; Hsieh, M.-H.; Yeh, H.-W.; Yang, S.-F.; Lin, C.-W.; Yeh, Y.-T.; Huang, J.-Y.; Liao, P.-L.; Chan, C.-H.; et al. Risk of Mortality and Readmission among Patients with Pelvic Fracture and Urinary Tract Infection: A Population-Based Cohort Study. Int. J. Environ. Res. Public Health 2021, 18, 4868. https://doi.org/10.3390/ijerph18094868

AMA Style

Chen Y-C, Chuang C-H, Hsieh M-H, Yeh H-W, Yang S-F, Lin C-W, Yeh Y-T, Huang J-Y, Liao P-L, Chan C-H, et al. Risk of Mortality and Readmission among Patients with Pelvic Fracture and Urinary Tract Infection: A Population-Based Cohort Study. International Journal of Environmental Research and Public Health. 2021; 18(9):4868. https://doi.org/10.3390/ijerph18094868

Chicago/Turabian Style

Chen, Ying-Cheng, Cheng-Hsun Chuang, Ming-Hong Hsieh, Han-Wei Yeh, Shun-Fa Yang, Chiao-Wen Lin, Ying-Tung Yeh, Jing-Yang Huang, Pei-Lun Liao, Chi-Ho Chan, and et al. 2021. "Risk of Mortality and Readmission among Patients with Pelvic Fracture and Urinary Tract Infection: A Population-Based Cohort Study" International Journal of Environmental Research and Public Health 18, no. 9: 4868. https://doi.org/10.3390/ijerph18094868

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop